SCHEMBL30442191

SCHEMBL30442191

CC(C)(C)OC(=O)N1CCC(Nc2ccc(C3CCC(=O)NC3=O)cn2)CC1

nearest known ligand 0.72

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 11/20 0.72
CRBN Q96SW2 11/20 0.72
ALDH1A1 P00352 2/20 0.47
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
JAK1 P23458 1/20 0.46
SYK P43405 1/20 0.46
PRMT5 O14744 1/20 0.45
GPR119 Q8TDV5 2/20 0.44
WNT3A P56704 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25221368 1.00 DDB1 (0.72) DDB1CRBNALDH1A1NPC1MAPT
SCHEMBL30442388 0.88 CRBN (0.56) DDB1CRBNJAK1SYKPRMT5
SCHEMBL30769278 0.87 DDB1 (0.67) DDB1CRBNALDH1A1NPC1MAPT
SCHEMBL25143681 0.85 DDB1 (0.67) DDB1CRBNMAPTPRMT5GPR119
SCHEMBL25074522 0.85 CRBN (0.70) DDB1CRBNGPR119
SCHEMBL30201627 0.85 CRBN (0.70) DDB1CRBNGPR119
SCHEMBL24881041 0.85 CRBN (0.70) DDB1CRBNGPR119
SCHEMBL30201796 0.85 DDB1 (0.67) DDB1CRBNMAPTPRMT5GPR119
SCHEMBL29208509 0.85 CRBN (0.70) DDB1CRBNGPR119
SCHEMBL29977355 0.85 CRBN (0.70) DDB1CRBNGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4430052-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF Nurix Therapeutics, Inc. (US) 2024-09-18 EP disclosed
WO-2023086399-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF NURIX THERAPEUTICS, INC. (US) 2023-05-19 WO disclosed